Page last updated: 2024-11-03

propentofylline and Astrocytoma, Grade IV

propentofylline has been researched along with Astrocytoma, Grade IV in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhruv, HD1
Roos, A1
Tomboc, PJ1
Tuncali, S1
Chavez, A1
Mathews, I1
Berens, ME1
Loftus, JC1
Tran, NL1
Jacobs, VL2
Landry, RP1
Liu, Y2
Romero-Sandoval, EA1
De Leo, JA2

Other Studies

3 other studies available for propentofylline and Astrocytoma, Grade IV

ArticleYear
Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
    Journal of neuro-oncology, 2016, Volume: 126, Issue:3

    Topics: Apoptosis; Blotting, Western; Brain Neoplasms; Cell Proliferation; Gene Expression Regulation, Neopl

2016
Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.
    Neuro-oncology, 2012, Volume: 14, Issue:2

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Central Nervous System; Disease Models, Animal; Gli

2012
Propentofylline targets TROY, a novel microglial signaling pathway.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Animals; Blotting, Western; Cell Movement; Flow Cytometry; Focal Adhesion Kinase 2; Glioblastoma; Im

2012